Biotechnology
Compare Stocks
2 / 10Stock Comparison
CDT vs BX
Revenue, margins, valuation, and 5-year total return — side by side.
Asset Management
CDT vs BX — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Biotechnology | Asset Management |
| Market Cap | $400K | $97.70B |
| Revenue (TTM) | $696M | $13.83B |
| Net Income (TTM) | $17M | $3.02B |
| Gross Margin | 36.9% | 86.0% |
| Operating Margin | 6.4% | 51.9% |
| Forward P/E | 0.0x | 20.9x |
| Total Debt | $1.29B | $13.31B |
| Cash & Equiv. | $390M | $2.63B |
CDT vs BX — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Mar 22 | May 26 | Return |
|---|---|---|---|
| CDT Equity Inc. (CDT) | 100 | 0.0 | -100.0% |
| Blackstone Inc. (BX) | 100 | 98.2 | -1.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CDT vs BX
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CDT is the clearest fit if your priority is growth exposure.
- EPS growth 128.8%
- 8.9% revenue growth vs BX's 21.6%
- Lower P/E (0.0x vs 20.9x)
BX carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 2 yrs, beta 1.53, yield 6.2%
- 487.1% 10Y total return vs CDT's -100.0%
- Lower volatility, beta 1.53, Low D/E 60.8%, current ratio 0.91x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 8.9% revenue growth vs BX's 21.6% | |
| Value | Lower P/E (0.0x vs 20.9x) | |
| Quality / Margins | 21.8% margin vs CDT's 2.4% | |
| Stability / Safety | Beta 1.53 vs CDT's 1.84, lower leverage | |
| Dividends | 6.2% yield; 2-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | -3.2% vs CDT's -99.8% | |
| Efficiency (ROA) | 6.5% ROA vs CDT's 1.0%, ROIC 16.1% vs 21.9% |
CDT vs BX — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CDT vs BX — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
BX leads this category, winning 4 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
BX is the larger business by revenue, generating $13.8B annually — 19.9x CDT's $696M. BX is the more profitable business, keeping 21.8% of every revenue dollar as net income compared to CDT's 2.4%.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $696M | $13.8B |
| EBITDAEarnings before interest/tax | $47M | $7.2B |
| Net IncomeAfter-tax profit | $17M | $3.0B |
| Free Cash FlowCash after capex | -$6M | $3.5B |
| Gross MarginGross profit ÷ Revenue | +36.9% | +86.0% |
| Operating MarginEBIT ÷ Revenue | +6.4% | +51.9% |
| Net MarginNet income ÷ Revenue | +2.4% | +21.8% |
| FCF MarginFCF ÷ Revenue | -0.9% | +12.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +100.4% | +41.3% |
Valuation Metrics
CDT leads this category, winning 4 of 4 comparable metrics.
Valuation Metrics
At 0.0x trailing earnings, CDT trades at a 100% valuation discount to BX's 32.1x P/E. On an enterprise value basis, CDT's 2.4x EV/EBITDA is more attractive than BX's 15.0x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $399,656 | $97.7B |
| Enterprise ValueMkt cap + debt − cash | $896M | $108.4B |
| Trailing P/EPrice ÷ TTM EPS | 0.00x | 32.14x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 20.89x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.54x |
| EV / EBITDAEnterprise value multiple | 2.43x | 15.02x |
| Price / SalesMarket cap ÷ Revenue | 0.00x | 7.07x |
| Price / BookPrice ÷ Book value/share | 0.00x | 4.45x |
| Price / FCFMarket cap ÷ FCF | — | 55.99x |
Profitability & Efficiency
CDT leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
BX delivers a 14.3% return on equity — every $100 of shareholder capital generates $14 in annual profit, vs $3 for CDT. BX carries lower financial leverage with a 0.61x debt-to-equity ratio, signaling a more conservative balance sheet compared to CDT's 1.02x. On the Piotroski fundamental quality scale (0–9), CDT scores 6/9 vs BX's 5/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +2.6% | +14.3% |
| ROA (TTM)Return on assets | +1.0% | +6.5% |
| ROICReturn on invested capital | +21.9% | +16.1% |
| ROCEReturn on capital employed | +22.2% | +16.9% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 |
| Debt / EquityFinancial leverage | 1.02x | 0.61x |
| Net DebtTotal debt minus cash | $896M | $10.7B |
| Cash & Equiv.Liquid assets | $390M | $2.6B |
| Total DebtShort + long-term debt | $1.3B | $13.3B |
| Interest CoverageEBIT ÷ Interest expense | -1.05x | 14.12x |
Total Returns (Dividends Reinvested)
BX leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in BX five years ago would be worth $16,476 today (with dividends reinvested), compared to $0 for CDT. Over the past 12 months, BX leads with a -3.2% total return vs CDT's -99.8%. The 3-year compound annual growth rate (CAGR) favors BX at 19.1% vs CDT's -97.4% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -93.7% | -19.8% |
| 1-Year ReturnPast 12 months | -99.8% | -3.2% |
| 3-Year ReturnCumulative with dividends | -100.0% | +68.9% |
| 5-Year ReturnCumulative with dividends | -100.0% | +64.8% |
| 10-Year ReturnCumulative with dividends | -100.0% | +487.1% |
| CAGR (3Y)Annualised 3-year return | -97.4% | +19.1% |
Risk & Volatility
BX leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
BX is the less volatile stock with a 1.53 beta — it tends to amplify market swings less than CDT's 1.84 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. BX currently trades 65.6% from its 52-week high vs CDT's 0.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.84x | 1.53x |
| 52-Week HighHighest price in past year | $1529.70 | $190.09 |
| 52-Week LowLowest price in past year | $1.20 | $101.73 |
| % of 52W HighCurrent price vs 52-week peak | +0.1% | +65.6% |
| RSI (14)Momentum oscillator 0–100 | 24.9 | 51.8 |
| Avg Volume (50D)Average daily shares traded | 126K | 7.2M |
Analyst Outlook
BX leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
BX is the only dividend payer here at 6.18% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy |
| Price TargetConsensus 12-month target | — | $156.29 |
| # AnalystsCovering analysts | — | 29 |
| Dividend YieldAnnual dividend ÷ price | — | +6.2% |
| Dividend StreakConsecutive years of raises | 1 | 2 |
| Dividend / ShareAnnual DPS | — | $7.70 |
| Buyback YieldShare repurchases ÷ mkt cap | +26.5% | +0.3% |
BX leads in 4 of 6 categories (Income & Cash Flow, Total Returns). CDT leads in 2 (Valuation Metrics, Profitability & Efficiency).
CDT vs BX: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is CDT or BX a better buy right now?
CDT Equity Inc.
(CDT) offers the better valuation at 0. 0x trailing P/E, making it the more compelling value choice. Analysts rate Blackstone Inc. (BX) a "Buy" — based on 29 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CDT or BX?
On trailing P/E, CDT Equity Inc.
(CDT) is the cheapest at 0. 0x versus Blackstone Inc. at 32. 1x.
03Which is the better long-term investment — CDT or BX?
Over the past 5 years, Blackstone Inc.
(BX) delivered a total return of +64. 8%, compared to -100. 0% for CDT Equity Inc. (CDT). Over 10 years, the gap is even starker: BX returned +487. 1% versus CDT's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CDT or BX?
By beta (market sensitivity over 5 years), Blackstone Inc.
(BX) is the lower-risk stock at 1. 53β versus CDT Equity Inc. 's 1. 84β — meaning CDT is approximately 20% more volatile than BX relative to the S&P 500. On balance sheet safety, Blackstone Inc. (BX) carries a lower debt/equity ratio of 61% versus 102% for CDT Equity Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — CDT or BX?
On earnings-per-share growth, the picture is similar: CDT Equity Inc.
grew EPS 128. 8% year-over-year, compared to 7. 2% for Blackstone Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CDT or BX?
Blackstone Inc.
(BX) is the more profitable company, earning 21. 8% net margin versus 8. 7% for CDT Equity Inc. — meaning it keeps 21. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BX leads at 51. 9% versus 11. 6% for CDT. At the gross margin level — before operating expenses — BX leads at 86. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Which pays a better dividend — CDT or BX?
In this comparison, BX (6.
2% yield) pays a dividend. CDT does not pay a meaningful dividend and should not be held primarily for income.
08Is CDT or BX better for a retirement portfolio?
For long-horizon retirement investors, Blackstone Inc.
(BX) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (6. 2% yield, +487. 1% 10Y return). CDT Equity Inc. (CDT) carries a higher beta of 1. 84 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (BX: +487. 1%, CDT: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between CDT and BX?
These companies operate in different sectors (CDT (Healthcare) and BX (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: CDT is a small-cap deep-value stock; BX is a mid-cap high-growth stock. BX pays a dividend while CDT does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.